Clearmind Medicine Inc.

CMND | NASDAQ | 1 Sledující

$1.16

16.00%

$0.16

Sledovat

Overview Metrics Financials

Breakdown	10/31/2024 USD	10/31/2023 USD	10/31/2022 CAD	10/31/2021 CAD
Total revenue	0 -	0 -	0 -	0 -
Cost of revenue	27 -52.61%	56 -50.31%	113 +4,308.20%	3 -
Gross profit	-27 +52.61%	-56 +50.31%	-113 -4,308.20%	-3 -
Operating expense	5,718 -34.58%	8,741 +2.45%	8,533 +132.10%	3,676 -
Operating income	-6,300 +27.93%	-8,741 -2.45%	-8,533 -147.11%	-3,453 -
Pretax Income	-4,877 +59.13%	-11,931 -27.33%	-9,370 -140.29%	-3,899 -
Tax Provision	378 +1,468.97%	24 -40.89%	41 -81.74%	223 -
Net income	-5,255 +56.05%	-11,955 -27.04%	-9,411 -128.27%	-4,123 -
EPS	-1.7 +96.02%	-42.58 +74.75%	-168.61 -76.24%	-95.67 -
Diluted EPS	-1.7 +96.02%	-42.58 +74.75%	-168.61 -76.24%	-95.67 -
Average Shares	4,265 +111.15%	2,020 +366.15%	433 +40.19%	309 -
Diluted Average Shares	4,265 +110.65%	2,025 +367.26%	433 +40.19%	309 -
EBIT	- -	-8,741 -2.64%	-8,516 -131.03%	-3,686 -
EBITDA	-5,854 +32.79%	-8,711 -2.65%	-8,486 -130.99%	-3,674 -

Soubory cookie používáme ke zlepšení prohlížení na webu.